Kintara Therapeutics Inc (KTRA)
0.1503
0.00 (0.00%)
USD |
NASDAQ |
May 10, 12:59
Kintara Therapeutics 1 Year Total Returns (Daily): -95.43% for May 9, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 09, 2024 | -95.43% |
May 08, 2024 | -95.36% |
May 07, 2024 | -95.44% |
May 06, 2024 | -95.70% |
May 03, 2024 | -96.53% |
May 02, 2024 | -94.69% |
May 01, 2024 | -94.88% |
April 30, 2024 | -94.39% |
April 29, 2024 | -94.13% |
April 26, 2024 | -94.69% |
April 25, 2024 | -94.66% |
April 24, 2024 | -95.71% |
April 23, 2024 | -95.92% |
April 22, 2024 | -96.48% |
April 19, 2024 | -96.24% |
April 18, 2024 | -96.89% |
April 17, 2024 | -96.94% |
April 16, 2024 | -96.23% |
April 15, 2024 | -96.12% |
April 12, 2024 | -95.61% |
April 11, 2024 | -95.74% |
April 10, 2024 | -95.83% |
April 09, 2024 | -95.92% |
April 08, 2024 | -95.84% |
April 05, 2024 | -96.29% |
Date | Value |
---|---|
April 04, 2024 | -96.02% |
April 03, 2024 | -95.82% |
April 02, 2024 | -97.16% |
April 01, 2024 | -97.22% |
March 28, 2024 | -97.14% |
March 27, 2024 | -97.52% |
March 26, 2024 | -97.56% |
March 25, 2024 | -97.58% |
March 22, 2024 | -97.53% |
March 21, 2024 | -97.68% |
March 20, 2024 | -97.52% |
March 19, 2024 | -97.66% |
March 18, 2024 | -97.64% |
March 15, 2024 | -97.14% |
March 14, 2024 | -96.43% |
March 13, 2024 | -96.06% |
March 12, 2024 | -97.19% |
March 11, 2024 | -97.16% |
March 08, 2024 | -97.60% |
March 07, 2024 | -97.55% |
March 06, 2024 | -97.95% |
March 05, 2024 | -97.83% |
March 04, 2024 | -97.99% |
March 01, 2024 | -97.95% |
February 29, 2024 | -97.86% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-98.67%
Minimum
Dec 11 2023
430.3%
Maximum
Mar 15 2021
-25.62%
Average
-74.85%
Median
May 16 2019
1 Year Total Returns (Daily) Benchmarks
ARCA biopharma Inc | 59.81% |
Shockwave Medical Inc | 15.88% |
Vanda Pharmaceuticals Inc | -26.45% |
Heron Therapeutics Inc | 20.49% |
Asensus Surgical Inc | -60.35% |